Ya Fu

发表

Adenosine Triphosphate in Serum as a Promising Biomarker for Differential Diagnosis of Hepatitis B Disease Progression

Q. Ou, Jiawei Zhang, Can Liu, 2022, Frontiers in Immunology.

Effect of mutations across reverse transcriptase region on HBV replication and progression of liver diseases in Chinese patients

Yin Sheng Zhang, Yin Zhang, Yuzhu Wu, 2022, Journal of clinical laboratory analysis.

The efficacy of addition of Tenofovir Disoproxil Fumarate to Peg-IFNα-2b is superior to the addition of Entecavir in HBeAg positive CHB patients with a poor response after 12 weeks of Peg-IFNα-2b treatment alone

Sheng Lin, Q. Ou, Yongbin Zeng, 2020, International journal of medical sciences.

IFIT3 Is Increased in Serum from Patients with Chronic Hepatitis B Virus (HBV) Infection and Promotes the Anti-HBV Effect of Interferon Alpha via JAK-STAT2 In Vitro

Q. Ou, Tianbin Chen, Can Liu, 2022, Microbiology spectrum.

Diagnostic Value of Detection of Pregenomic RNA in Sera of Hepatitis B Virus-Infected Patients with Different Clinical Outcomes

Q. Ou, Jinpiao Lin, Can Liu, 2019, Journal of Clinical Microbiology.

Diagnostic value of serum pgRNA detection in HBV-infected patients with different clinical outcomes.

Q. Ou, Jinpiao Lin, Can Liu, 2019, Journal of clinical microbiology.

Gut microbiota dysbiosis in patients with hepatitis B virus–induced chronic liver disease covering chronic hepatitis, liver cirrhosis and hepatocellular carcinoma

Q. Ou, Yongbin Zeng, Bin Yang, 2020, Journal of viral hepatitis.

Mutational characterization of HBV reverse transcriptase gene and the genotype-phenotype correlation of antiviral resistance among Chinese chronic hepatitis B patients

Q. Ou, Yongbin Zeng, Tianbin Chen, 2020, Emerging microbes & infections.

Characterization and Clinical Significance of Natural Variability in Hepatitis B Virus Reverse Transcriptase in Treatment-Naive Chinese Patients by Sanger Sequencing and Next-Generation Sequencing

Shuxiang Wu, Q. Ou, Yongbin Zeng, 2019, Journal of Clinical Microbiology.

Association between mitochondrial DNA content and baseline serum levels of HBsAg in chronic hepatitis B infection

Q. Ou, Yongbin Zeng, Jinpiao Lin, 2017, Journal of medical virology.

Compartmentalisation of Hepatitis B virus X gene evolution in hepatocellular carcinoma microenvironment and the genotype-phenotype correlation of tumorigenicity in HBV-related patients with hepatocellular carcinoma

Q. Ou, Yongbin Zeng, Ling Jiang, 2022, Emerging microbes & infections.

Background: Interferon (IFN)-a is widely used for the treatment of chronic hepatitis B (CHB) infection due to the high rate of hepatitis B surface antigen (HBsAg) sero-

Shuxiang Wu, Q. Ou, Jinpiao Lin, 2018 .

RIG-I Enhances Interferon-α Response by Promoting Antiviral Protein Expression in Patients with Chronic Hepatitis B

Shuxiang Wu, Q. Ou, Jinpiao Lin, 2018, Antiviral therapy.

Using machine learning models to predict HBeAg seroconversion in CHB patients receiving pegylated interferon‐α monotherapy

Q. Ou, Yongbin Zeng, Tianbin Chen, 2022, Journal of clinical laboratory analysis.

Real-time PCR for quantitative detection of mitochondrial DNA from peripheral blood mononuclear cell in patients with HBV-related hepatocellular carcinoma

Q. Ou, Jinpiao Lin, Tianbin Chen, 2017 .

miR-548c-3p targets TRIM22 to attenuate the Peg-IFN-α therapeutic efficacy in HBeAg-positive patients with chronic hepatitis B.

Q. Ou, Jinpiao Lin, Shaoying Guo, 2023, Antiviral research.